Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway
Authors
Keywords
Non-mitogenic FGF2, Acute doxorubicin cardiotoxicity, CK2-HO-1 signaling, Oxidized phospholipids, Rat cardiomyocytes
Journal
CELL AND TISSUE RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-30
DOI
10.1007/s00441-018-2905-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia
- (2017) Loredana Salerno et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion
- (2017) Riya Ganguly et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
- (2016) Roberto Marques Damiani et al. ARCHIVES OF TOXICOLOGY
- The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab–Mediated Cardiac Dysfunction
- (2016) Vineet Goyal et al. CANADIAN JOURNAL OF CARDIOLOGY
- Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
- (2016) Dong Li et al. CANCER LETTERS
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- A whole blood–based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion
- (2015) Christopher W. White et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling
- (2014) Jon-Jon Santiago et al. PLoS One
- Congenital Absence of Nitric Oxide Synthase 3 Potentiates Cardiac Dysfunction and Reduces Survival in Doxorubicin- and Trastuzumab-Mediated Cardiomyopathy
- (2013) Matthew Zeglinski et al. CANADIAN JOURNAL OF CARDIOLOGY
- FGF-2 and FGF-16 Protect Isolated Perfused Mouse Hearts from Acute Doxorubicin-Induced Contractile Dysfunction
- (2013) David P. Sontag et al. Cardiovascular Toxicology
- Role of oxidized phospholipids in cardiovascular pathology
- (2013) David Allen et al. Clinical Lipidology
- A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death
- (2013) Christopher W. White et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions
- (2012) Dilu Feng et al. ANGIOGENESIS
- Structural Identification and Cardiovascular Activities of Oxidized Phospholipids
- (2012) Robert G. Salomon CIRCULATION RESEARCH
- Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes
- (2010) Jon-Jon Santiago et al. CARDIOVASCULAR RESEARCH
- Protein Kinase CK2 in Health and Disease
- (2009) J. H. Trembley et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started